Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Zaltzman

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Clinical Transplantation|January 22, 2005
A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipientsJeffrey S Zaltzman, Anne Boucher, Stephan Busque, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantationS V Jassal, J M Roscoe, J S Zaltzman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)G V Ramesh Prasad, S Joseph Kim, Michael Huang, et al.
Transplantation|October 15, 2008
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failureAnthony Jevnikar, Dianne Arlen, Brendan Barrett, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Transplantation|October 14, 2006
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipientsS Joseph Kim, G V Ramesh Prasad, Michael Huang, et al.
Biochemical and Biophysical Research Communications|July 5, 2015
IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancerElise K Heon, Hasi Wulan, Loch P Macdonald, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Transplantation|January 22, 2005
A prospective 3-yr evaluation of tacrolimus-based immunosuppressive therapy in immunological high risk renal allograft recipientsJeffrey S Zaltzman, Anne Boucher, Stephan Busque, et al.
Journal of the American Society of Nephrology : JASN|September 4, 1998
Clinical practice guidelines: prevention of cytomegalovirus disease after renal transplantationS V Jassal, J M Roscoe, J S Zaltzman, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|October 13, 2004
Reduced incidence of new-onset diabetes mellitus after renal transplantation with 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors (statins)G V Ramesh Prasad, S Joseph Kim, Michael Huang, et al.
Transplantation|October 15, 2008
Five-year study of tacrolimus as secondary intervention versus continuation of cyclosporine in renal transplant patients at risk for chronic renal allograft failureAnthony Jevnikar, Dianne Arlen, Brendan Barrett, et al.
Transplantation Research|February 2, 2013
A pilot study of reduced dose cyclosporine and corticosteroids to reduce new onset diabetes mellitus and acute rejection in kidney transplant recipientsEdward H Cole, G V Ramesh Prasad, Carl J Cardella, et al.
Transplantation|October 14, 2006
A comparison of the effects of C2-cyclosporine and C0-tacrolimus on renal function and cardiovascular risk factors in kidney transplant recipientsS Joseph Kim, G V Ramesh Prasad, Michael Huang, et al.
Biochemical and Biophysical Research Communications|July 5, 2015
IL-15 induces strong but short-lived tumor-infiltrating CD8 T cell responses through the regulation of Tim-3 in breast cancerElise K Heon, Hasi Wulan, Loch P Macdonald, et al.
Pageof 8